Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease-Reference-Cited by-同舟云学术

Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease

Published:2017-01 Issue:1 Volume:66 Page:132-141
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Gariani Karim,Ryu Dongryeol,Menzies Keir J.,Yi Hyon-Seung,Stein Sokrates,Zhang Hongbo,Perino Alessia,Lemos Vera,Katsyuba Elena,Jha Pooja,Vijgen Sandrine,Rubbia-Brandt Laura,Kim Yong Kyung,Kim Jung Tae,Kim Koon Soon,Shong Minho,Schoonjans Kristina,Auwerx Johan

Publisher

Elsevier BV

Subject

Hepatology

Reference53 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

2. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013;Ng;Lancet,2014

3. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside;Gariani;Diabetes Metab,2013

4. Non-alcoholic fatty liver disease;Sattar;BMJ,2014

5. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting organ-specific mitochondrial dysfunction to improve biological aging;Pharmacology & Therapeutics;2024-10

2. Clonorchis sinensis aggravated liver fibrosis by activating PARP-1 signaling to induce parthanatos via DNA damage;Veterinary Parasitology;2024-08

3. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH;Journal of Hepatology;2024-08

4. ANTI-OBESITY NUTRACEUTICALS: INSIGHTS INTO MECHANISMS OF ACTION AND POTENTIAL USE OF BIOCOMPATIBLE NANOCARRIERS FOR DELIVERY;International Journal of Applied Pharmaceutics;2024-07-07

5. ADP-ribosylation, a multifaceted modification: Functions and mechanisms in aging and aging-related diseases;Ageing Research Reviews;2024-07